Abstract

BackgroundReversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC). Most of patients with RESLES associated with encephalitis/encephalopathy were identified in Japanese population, but almost no Chinese patients were diagnosed as RESLES associated with encephalitis/encephalopathy.MethodsPossible patients with reversible isolated SCC lesions were retrieved from January 2012 to July 2015 using keyword “restricted diffusion and isolated SCC lesion” in MRI report system from a large academic center. The clinical, laboratory and radiological data were summarized.ResultsA total of 15 encephalitis/encephalopathy patients (9 males and 6 females) were identified with a reversible isolated SCC lesion. Except for 13 patients with fever symptom, 8 patients also had cold symptoms before the onset of neurological symptoms. The neurological symptoms included headache, vertigo, seizure, disturbance of consciousness, and delirious behavior. Thirteen patients completely recovered within 1 month, but 2 patients who were subjected to mechanical ventilation had persistent neurological deficits. The initial MRI features showed isolated ovoid or extending SCC lesions with homogeneous hyperintense on diffusion weighted imaging (DWI) and decreased apparent diffusion coefficient (ADC) values. The follow-up MRI revealed that isolated SCC lesions with diffuse restriction disappeared at 10 to 32 days after the initial MRI study. Fractional anisotropy map revealed the decreased value of SCC lesion in a severe case with poor prognosis.ConclusionsRESLES associated with encephalitis/encephalopathy is a reversible syndrome with an excellent prognosis in most patients, while a few patients required ventilator supporting at the early stage might have severe neurological sequelae. Reversible signal changes on DWI and ADC are identified in all patients, but fractional anisotropy values can be decreased in severe patient with neurological sequelae.Electronic supplementary materialThe online version of this article (doi:10.1186/s12883-016-0572-9) contains supplementary material, which is available to authorized users.

Highlights

  • Reversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC)

  • The neurological symptoms of RESLES associated with encephalitis/encephalopathy can presented with delirious behavior, short disturbance of consciousness, and seizures, but usually had complete recovery without neurological sequelae after a short disease course [9,10,11]

  • At sometimes, RESLES associated with encephalitis/encephalopathy was interchangeably termed as clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) [12, 13]

Read more

Summary

Introduction

Reversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC). Most of patients with RESLES associated with encephalitis/ encephalopathy were identified in Japanese population, but almost no Chinese patients were diagnosed as RESLES associated with encephalitis/encephalopathy. Reversible splenial lesion syndrome (RESLES) is characterized by reversible lesion in the central portion of the splenium of corpus callosum (SCC) [1, 2]. RESLES is most often identified in patients with seizures and/or antiepileptic drugs withdrawal [3, 4] It is frequently observed in encephalitis/encephalopathy caused by various pathogens such as influenza virus, rotavirus, measles, herpesvirus 6, adenovirus, mumps, Epstein-Barr virus, Escherischia coli, and others [5,6,7,8]. We described the clinical data and outcomes in 15 Chinese patients with RESLES associated with encephalitis/encephalopathy identified retrospectively in order to evaluate the clinical heterogeneity of RESLES associated with encephalitis/encephalopathy

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call